Literature DB >> 11488330

Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease.

J G Gea1, M Pasto, M A Carmona, M Orozco-Levi, J Palomeque, J Broquetas.   

Abstract

The purpose of this study was to analyse key enzyme activities of the deltoid muscle (DM) in chronic obstructive pulmonary disease (COPD) patients. The activities of one oxidative enzyme (citrate synthase (CS)), two glycolytic enzymes (lacatate dehydrogenase (LD); and phosphofructokinase (PFK)) and one enzyme related to the use of energy stores (creatine kinase (CK)) were determined in the DM of 10 patients with COPD and nine controls. Exercise capacity (cycloergometry) and the handgrip strength were also evaluated. Although exercise capacity was markedly reduced in COPD (57 +/- 20% predicted), their handgrip strength was relatively preserved (77 +/- 19% pred). The activity of LD was higher in the COPD patients (263.9 +/- 68.2 versus 184.4 +/- 46.5 mmol x min(-1) x g(-1), p<0.01), with a similar trend for CS (67.3 +/- 33.3 versus 46.0 +/- 17.4 mmol x min(-1) x g(-1), p = 0.07). Interestingly, the activity of the latter enzyme was significantly higher than controls if only severe COPD patients were considered (81.8 +/- 31.2 mmol x min(-1) x g(-1), p < 0.01). PFK and CK activities were similar for controls and COPD. Chronic obstructive patients show a preserved or even increased (severe disease) oxidative capacity in their deltoid muscle. This coexists with a greater capacity in the anaerobic part of the glycolysis. These findings are different to those previously observed in muscles of the lower limbs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488330     DOI: 10.1183/09031936.01.17509390

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  26 in total

1.  Elevated TNFalpha production in whole blood in patients with severe COPD: the potential link to disease severity.

Authors:  Stephan von Haehling; Nicholas S Hopkinson; Michael I Polkey; Margit Niethammer; Stefan D Anker; Sabine Genth-Zotz
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

2.  Sex differences in function and structure of the quadriceps muscle in chronic obstructive pulmonary disease patients.

Authors:  Pilar Ausín; Juana Martínez-Llorens; Marina Sabaté-Bresco; Carme Casadevall; Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-12-06       Impact factor: 2.444

3.  Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.

Authors:  Markus Amann; Mark S Regan; Majd Kobitary; Marlowe W Eldridge; Urs Boutellier; David F Pegelow; Jerome A Dempsey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-05       Impact factor: 3.619

Review 4.  Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction.

Authors:  Joaquim Gea; Carme Casadevall; Sergi Pascual; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

5.  Microbiopsies versus Bergström needle for skeletal muscle sampling: impact on maximal mitochondrial respiration rate.

Authors:  M E Isner-Horobeti; A Charton; F Daussin; B Geny; S P Dufour; R Richard
Journal:  Eur J Appl Physiol       Date:  2014-01-22       Impact factor: 3.078

Review 6.  Can muscle protein metabolism be specifically targeted by exercise training in COPD?

Authors:  Davina C M Simoes; Ioannis Vogiatzis
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

7.  Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice.

Authors:  I Mark Olfert; Richard A Howlett; Kechun Tang; Nancy D Dalton; Yusu Gu; Kirk L Peterson; Peter D Wagner; Ellen C Breen
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

8.  Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.

Authors:  Ariel Jaitovich; Esther Barreiro
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

9.  Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease.

Authors:  W D-C Man; M G G Soliman; D Nikoletou; M L Harris; G F Rafferty; N Mustfa; M I Polkey; J Moxham
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

Review 10.  Factors contributing to muscle wasting and dysfunction in COPD patients.

Authors:  Rob C I Wüst; Hans Degens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.